Streptase vs. Kinlytic

Are Streptase and Kinlytic the Same Thing?

Streptase (streptokinase) and Kinlytic (urokinase) are used to treat blood clots in the lungs (pulmonary embolism).

Streptase is also used to treat heart attack as well as blood clots in the legs (deep venous thrombosis-DVT).

  • The brand names Streptase and Kinlytic are no longer available in the U.S. Generic versions may be available.
  • Streptase is an enzyme and Kinlytic is a thrombolytic agent.
  • Side effects of Streptase and Kinlytic that are similar include easy bruising or bleeding.
  • Side effects of Streptase that are different from Kinlytic include nausea, headache, dizziness, low blood pressure, mild fever, rash, itching, flushing, muscle or bone pain, shivering, allergic reactions, and nerve damage.
  • Both Streptase and Kinlytic may interact with blood thinners, aspirin or other nonsteroidal anti-inflammatory drugs (NSAIDs), and medications used to prevent blood clots.

What Are Possible Side Effects of Streptase?

Common side effects of Streptase include:

  • nausea,
  • headache,
  • dizziness,
  • low blood pressure,
  • mild fever,
  • bleeding from wounds or gums,
  • rash,
  • itching,
  • flushing,
  • muscle or bone pain,
  • shivering, and
  • allergic reactions.

Streptase can also cause nerve damage.

What Are Possible Side Effects of Kinlytic?

Common side effects of Kinlytic (urokinase) include:

  • easy bruising or
  • bleeding

Other side effects of Kinlytic are uncommon, but can be severe such as:

  • fever
  • stroke
  • trouble breathing
  • blood in your stools
  • coughing up blood
  • chest pain
  • problems with speech
  • vision problems
  • swelling
  • discoloration of your fingers or toes
  • severe stomach pain
  • chills, or
  • flu symptoms

See your doctor if you have any side effects.

What Is Streptase?

Streptase (streptokinase) is an enzyme used in the treatment of heart attack or lung blood clots (pulmonary embolism) as well as leg blood clots (deep venous thrombosis-DVT). The brand name drug Streptase is no longer available in the U.S. Generic versions may be available.

What Is Kinlytic?

Kinlytic (urokinase) for Injection is a thrombolytic agent used to treat blood clots in the lungs. The brand name Kinlytic is discontinued, but generic versions may be available.

What Drugs Interact With Streptase?

Streptase may interact with blood thinners, non-steroidal anti-inflammatory drugs (NSAIDs), or aspirin. Drugs that can reverse effects of streptokinase include aminocaproic acid, aprotinin, and tranexamic acid. Tell your doctor all medications you are taking.

What Drugs Interact With Kinlytic?

Kinlytic may interact with blood thinners, aspirin or NSAIDs (nonsteroidal anti-inflammatory drugs), or medications used to prevent blood clots. Tell your doctor all medications and supplements you use. Kinlytic is not expected to be harmful to a fetus. However, your doctor should know if you are pregnant before you receive this medication. It is unknown if this drug passes into breast milk or if it could harm a nursing baby. Consult your doctor before breastfeeding. 
 

How Should Streptase Be Taken?

Streptase (streptokinase) is given by injection by a health care professional. Dose is dependent upon the condition of the patient and response to treatment.

How Should Kinlytic Be Taken?

The loading dose of 4,400 international units per kilogram of Kinlytic injection is given at a rate of 90 mL per hour over a period of 10 minutes. This is followed with a continuous infusion of 4,400 international units per kilogram per hour at a rate of 15 mL for 12 hours.

From WebMD Logo

Featured Centers
Health Solutions From Our Sponsors
Disclaimer

All drug information provided on RxList.com is sourced directly from drug monographs published by the U.S. Food and Drug Administration (FDA).

Any drug information published on RxList.com regarding general drug information, drug side effects, drug usage, dosage, and more are sourced from the original drug documentation found in its FDA drug monograph.

Drug information found in the drug comparisons published on RxList.com is primarily sourced from the FDA drug information. The drug comparison information found in this article does not contain any data from clinical trials with human participants or animals performed by any of the drug manufacturers comparing the drugs.

The drug comparisons information provided does not cover every potential use, warning, drug interaction, side effect, or adverse or allergic reaction. RxList.com assumes no responsibility for any healthcare administered to a person based on the information found on this site.

As drug information can and will change at any time, RxList.com makes every effort to update its drug information. Due to the time-sensitive nature of drug information, RxList.com makes no guarantees that the information provided is the most current.

Any missing drug warnings or information does not in any way guarantee the safety, effectiveness, or the lack of adverse effects of any drug. The drug information provided is intended for reference only and should not be used as a substitute for medical advice.

If you have specific questions regarding a drug’s safety, side effects, usage, warnings, etc., you should contact your doctor or pharmacist, or refer to the individual drug monograph details found on the FDA.gov or RxList.com websites for more information.

You may also report negative side effects of prescription drugs to the FDA by visiting the FDA MedWatch website or calling 1-800-FDA-1088.

References
Medscape. Streptase Drug Information.

https://www.medscape.com/answers/811234-88119/what-is-the-fda-recommended-regimen-of-streptokinase-for-thrombolytic-therapy-of-pulmonary-embolism-pe

Health Solutions From Our Sponsors